2022-11-07 |
1 |
Complaint |
U.S. Patent Nos. 8,592,362; 9,000,011; 9,095,584;
9,480,682; 9,987,263; 9,999,618; 10,076,514; 10,251,873…civil action for patent infringement of U.S. Patent Nos. 9,000,011 (the
“ʼ011 Patent”), 9,987,263 (the…the “ʼ263 Patent”), 10,383,864 (the “ʼ864 Patent”), 10,406,143 (the
“ʼ143 Patent”), 9,999,618 (the “ʼ618…“ʼ618 Patent”), 10,925,866 (the “ʼ866 Patent”), 10,813,921 (the
“ʼ921 Patent”), and RE48,608 (“RE608”…RE608”) (collectively, “Patents-in-Suit”), arising under the patent
laws of the United States, Title 35, |
External link to document |
2023-01-20 |
16 |
Stipulation-General (See Motion List for Stipulation to Extend Time) |
U.S. Patent Nos. 8,592,362, 9,095,584, 9,480,682, 10,525,045, 11,033,538, 11,241,422, 10,251,873, 10,471,053… 7 November 2022
1:22-cv-01461
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |
2023-01-20 |
17 |
Stipulation-General (See Motion List for Stipulation to Extend Time) |
STIPULATION and Covenant Not to Sue re: U.S. Patent Nos. 10,076,514 and 11,234,972 by Amicus Therapeutics US… 7 November 2022
1:22-cv-01461
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |
2023-01-23 |
18 |
SO ORDERED |
U.S. Patent Nos. 8,592,362, 9,095,584, 9,480,682, 10,525,045, 11,033,538, 11,241,422, 10,251,873, 10,471,053… 7 November 2022
1:22-cv-01461
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |